Takeaways from Our Prop. GLP1+Patient Data Analyses: Tirzepatide Remains King
Earnest Analytics partnered with the BMO Capital Markets’ BioPharma team to add insight into GLP1 therapeutic usage.
Telehealth prescription continues to be common in this category of therapeutics, though interestingly, there appears to be a divergence between T2D treatments and Obesity treatments. We took a look at telehealth prescription trends to get a better understanding of the rise in alternative sites of care for patients looking to gain access to these therapeutics.
